GTx Inc (GTXI) - Financial and Strategic SWOT Analysis Review

GTx Inc (GTXI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers including breast and prostate cancer; and other serious medical conditions. The company is further focused on developing selective androgen receptor modulators (SARMs), a class of drugs that have the potential to be used as a hormonal therapy for treating advanced breast cancer and other serious medical conditions, such as stress urinary incontinence (SUI) and Duchenne muscular dystrophy (DMD). GTx is developing enobosarm, a SARM in Phase II trials for treating breast cancer and stress urinary incontinence. GTx is headquartered in Memphis, Tennessee, the US.

GTx Inc Key Recent Developments

May 15,2018: GTx Provides Corporate Update and Reports First Quarter 2018 Financial Results
Mar 12,2018: GTx Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 14,2017: GTx Provides Corporate Update and Reports Third Quarter 2017 Financial Results
Aug 14,2017: GTx Provides Corporate Update and Reports Second Quarter 2017 Financial Results
May 15,2017: GTx Provides Corporate Update and Reports First Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
GTx Inc - Key Facts 5
GTx Inc - Key Employees 6
GTx Inc - Key Employee Biographies 7
GTx Inc - Major Products and Services 8
GTx Inc - History 9
GTx Inc - Company Statement 11
GTx Inc - Locations And Subsidiaries 13
Head Office 13
Section 2 Company Analysis 14
GTx Inc - Business Description 14
GTx Inc - SWOT Analysis 15
SWOT Analysis - Overview 15
GTx Inc - Strengths 15
GTx Inc - Weaknesses 16
GTx Inc - Opportunities 17
GTx Inc - Threats 18
GTx Inc - Key Competitors 19
Section 3 Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 Companys Lifesciences Financial Deals and Alliances 26
GTx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
GTx Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
GTx Inc, Recent Deals Summary 28
Section 5 Companys Recent Developments 29
May 15, 2018: GTx Provides Corporate Update and Reports First Quarter 2018 Financial Results 29
Nov 14, 2017: GTx Provides Corporate Update and Reports Third Quarter 2017 Financial Results 31
Aug 14, 2017: GTx Provides Corporate Update and Reports Second Quarter 2017 Financial Results 33
May 15, 2017: GTx Provides Corporate Update and Reports First Quarter 2017 Financial Results 35
Mar 15, 2017: GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2016 Financial Results 37
Section 6 Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43

List Of Tables

List of Tables
GTx Inc, Key Facts 5
GTx Inc, Key Employees 6
GTx Inc, Key Employee Biographies 7
GTx Inc, Major Products and Services 8
GTx Inc, History 9
GTx Inc, Key Competitors 19
GTx Inc, Ratios based on current share price 20
GTx Inc, Annual Ratios 21
GTx Inc, Annual Ratios (Cont...1) 22
GTx Inc, Interim Ratios 24
GTx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
GTx Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
GTx Inc, Recent Deals Summary 28
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42

List Of Figures

List of Figures
GTx Inc, Performance Chart (2013 - 2017) 23
GTx Inc, Ratio Charts 25
GTx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
GTx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27

GTx Inc (GTXI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers

USD 250 View Report

GTx Inc (GTXI) - Financial and Strategic SWOT Analysis Review

GTx Inc (GTXI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125 View Report

GTx Inc (GTXI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers

USD 250 View Report

GTx Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

GTx Inc Company Profile is a detailed strategic and analytical report on GTx Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available